One diagnosis of cancer in a family is heartbreaking, however it's another story for the Nolan sisters who have seen the ...

TAK-186 is under clinical development by Takeda Pharmaceutical and currently in Phase II for Metastatic Colorectal Cancer.

The findings improve our understanding of cancer and open the door to new treatments for metastatic disease ... a common feature of cancer cell growing in the lung,” said Professor Sarah ...

Here, we describe the contribution of hepatocyte ferroptosis to CD8 + T cell activation in a model of primary HCC and metastatic colon cancer and identify the complex interaction between cancer, ...

Scientists have revealed new insights into the origin of liver ... cancer," said Karin. "This study helps reveal the underlying molecular biology that allows cells to re-enter the cell cycle ...

These images show slices of mouse liver under the microscope ... but this introduces a paradox since senescence is supposed to guard against cancer,” said Karin. “This study helps reveal the ...

Scientists at University of California San Diego School of Medicine have shed new light on the development of liver cancer ... allows cells to re-enter the cell cycle after undergoing senescence ...

Lung cancer is one of the most common cancers. Stage 1 lung cancer is defined by tumors that are very small and have not spread (metastasized) to other parts of the body. Despite its name, it is ...

The FDA approved the FoundationOne Liquid CDx to identify patients with metastatic non–small cell lung cancer (mNSCLC) with MET exon 14 skipping alterations who may be eligible for tepotinib ...

Vebreltinib DR is under clinical development by Apollomics and currently in Phase II for Non-Small Cell Lung Cancer.